Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          Enter the terms you wish to search for.
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations Breadcrumb
    Home
                              Blog
                              Exploring the Ethics & Practice of Psychedelics Research
 Navigate to:
  Categories
    Coronavirus (12)
        Health IT (11)
        Fraud (1)
        Grants and Contracts (1)
        Research (5)
        Prevention and Wellness (19)
        Health Data (6)
        Holidays and Observances (14)
        Global Health (4)
        Public Health and Safety (21)
        HIPAA (3)
        Programs for Families and Children (5)
        Americans with Disabilities Act (1)
        Mental Health and Substance Abuse (1)
        Vaccines (1)
        HHS Administrative (4)
        LGBT (1)
        Emergency Preparedness and Response (1)Text resize icon

                    




Exploring the Ethics & Practice of Psychedelics Research








  
  
    

  
      **August 22, 2023**
                |
        By:  Julie        Kaneshiro, Acting Director, Office for Human Research Protections (OHRP)

  
**Summary:**
  





On September 14, 2023, OHRP will host its 6th Annual Exploratory Workshop: Exploring the Ethical and Practical Considerations of Psychedelics Research.


      At the U.S. Department of Health and Human Services (HHS), we are committed to addressing the suffering many Americans experience from mental health and substance use issues, many of which have been exacerbated by the COVID-19 pandemic. With the aim of considering all promising and innovative approaches to addressing our nation’s mental health and substance use crisis, HHS is interested in exploring the potential of psychedelic-assisted therapies as treatments for a myriad of mental health conditions.

Psychedelics are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. Their origins predate written history, and traditional use as a sacred sacrament in religious ceremonial healing practices continues to this day. Renewed interest in the therapeutic potential of psychedelics has grown in recent years, evidenced by an increase in basic science and clinical research, and a growing amount of legislative activity in states across the nation.  While there are many completed and ongoing studies with such products for treatment of diseases and medical conditions, more clinical trials are needed to establish the safety, efficacy, and appropriate use criteria for psychedelics. The Food and Drug Administration has recently published draft guidance providing general considerations to sponsors developing psychedelic drugs for treatment of medical conditions, including considerations for non-clinical studies and clinical trials. The conduct of psychedelic research with human participants also requires robust and nuanced consideration of several ethical, legal, and practical issues.

The mission of the Office for Human Research Protections (OHRP) is to protect the rights, welfare, and well-being of people who participate in research studies that HHS supports or conducts. On **Thursday, September 14, 2023, OHRP will host its 6th Annual Exploratory Workshop: *Exploring the Ethical and Practical Considerations of Psychedelics Research*.** The workshop provides a platform for a group of experts to deliberate on the ethical, practical, and legal questions pertaining to psychedelic research, including issues around informed consent, study design and integrity, protection and inclusion of vulnerable groups, the unique risk considerations, as well as preserving public trust. This is a timely and important discussion that responds to tremendous interest in this topic from diverse stakeholders, including patients, researchers, funders, regulators, and policymakers at both the state and federal levels. I hope that you will join me and my OHRP colleagues at this event!

This free event will be **streamed live around the world on Thursday, September 14, 2023 from 9:45 a.m. to 4:15 p.m. EST**. Visit the event website for details and access to the video.
  Posted In:
  Research | Public Health and SafetySign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases

Sign Up







  Subscribe to RSS
    

      Receive latest updates

                    
  


Related Blog Posts
    

      Donate Blood and Help Save Lives
  

The U.S. Department of Health and Human Services Is Taking Action to Strengthen Primary Care
  

Improving Data to Support the Home- and Community-Based Workforce Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility Statement
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​